About The Mito Foundation
New research into nucleoside therapy aims to develop a treatment for deadly mitochondrial disease
Read our media release about a pioneering project we are co-funding with The Lily Foundation.
First IVF Baby Turns 40
Happy 40 birthday Louise Brown! Louise’s birth was ground breaking and provided hope to millions of couples.
Senate Report about Mitochondrial Donation Released
Senate Committee recommends pathway to legislative change so Australian babies don’t suffer with mitochondrial disease.
Mito Connect Call
18 August 2018
The Bloody Long Walk – Adelaide
19 August 2018
Melbourne Paediatric Mito Information Day
8 September 2018
EXPERT REACTION: Senate report on allowing ‘three person IVF’ to prevent mitochondrial disease
Read about expert reactions to the Senate Report on mitochondrial donation.
Stealth Raises $100M to Advance Elamipretide as Treatment for Mitochondrial Diseases
Further development of Elamipretide as treatment for Leber’s hereditary optic neuropathy (LHON), mitochondrial myopathy, Barth syndrome, and age-related macular degeneration.
FDA Grants NeuroVive’s KL1333 Orphan Drug Status for Treatment of Mitochondrial Diseases
Orphan Drug Designation of compound KL1333 is a positive step towards bringing such treatment to patients of inherited mitochondrial respiratory chain diseases in the US.